R
René-Olivier Mirimanoff
Researcher at University Hospital of Lausanne
Publications - 72
Citations - 13673
René-Olivier Mirimanoff is an academic researcher from University Hospital of Lausanne. The author has contributed to research in topics: Radiation therapy & Cancer. The author has an hindex of 31, co-authored 72 publications receiving 12316 citations. Previous affiliations of René-Olivier Mirimanoff include University of Lausanne & University of St. Gallen.
Papers
More filters
Journal ArticleDOI
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp,Monika E. Hegi,Warren P. Mason,Martin J. van den Bent,Martin J.B. Taphoorn,Robert C. Janzer,Samuel K. Ludwin,Anouk Allgeier,Barbara Fisher,Karl Belanger,Peter Hau,Alba A. Brandes,J.M.M. Gijtenbeek,Christine Marosi,Charles J. Vecht,Karima Mokhtari,Pieter Wesseling,Salvador Villà,Elizabeth Eisenhauer,Thierry Gorlia,Michael Weller,Denis Lacombe,J. Gregory Cairncross,René-Olivier Mirimanoff +23 more
TL;DR: Benefits of adjuvant temozolomide with radiotherapy lasted throughout 5 years of follow-up, and a benefit of combined therapy was recorded in all clinical prognostic subgroups, including patients aged 60-70 years.
Journal ArticleDOI
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial.
Michel Bolla,Laurence Collette,Leo E.C.M. Blank,Padraig Warde,Jean Bernard Dubois,René-Olivier Mirimanoff,Guy Storme,Jacques Bernier,Abraham Kuten,Cora N. Sternberg,J Mattelaer,José Lopez Torecilla,J Rafael Pfeffer,Carmel Lino Cutajar,A Zurlo,Marianne Pierart +15 more
TL;DR: Immediate androgen suppression with an LHRH analogue given during and for 3 years after external irradiation improves disease-free and overall survival of patients with locally advanced prostate cancer.
Journal ArticleDOI
Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin
Michel Bolla,Dionisio Gonzalez,Padraig Warde,Jean Bernard Dubois,René-Olivier Mirimanoff,Guy Storme,Jacques Bernier,Abraham Kuten,Cora N. Sternberg,Thierry Gil,Laurence Collette,Marianne Pierart +11 more
TL;DR: Adjuvant treatment with goserelin, when started simultaneously with external irradiation, improves local control and survival in patients with locally advanced prostate cancer.
Journal ArticleDOI
Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial.
M. J. van den Bent,D Afra,O De Witte,M Ben Hassel,S. Schraub,Khê Hoang-Xuan,Per-Uno Malmström,Laurence Collette,Marianne Pierart,René-Olivier Mirimanoff,Abmf Karim +10 more
TL;DR: Early radiotherapy after surgery lengthens the period without progression but does not affect overall survival, and Radiotherapy could be deferred for patients with low-grade glioma who are in a good condition, provided they are carefully monitored.
Journal ArticleDOI
External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study
Michel Bolla,Geertjan van Tienhoven,Padraig Warde,Jean Bernard Dubois,René-Olivier Mirimanoff,Guy Storme,Jacques Bernier,Abraham Kuten,Cora N. Sternberg,Ignace Billiet,José Lopez Torecilla,Raphael Pfeffer,Carmel Lino Cutajar,Theodore H. van der Kwast,Laurence Collette +14 more
TL;DR: In patients with prostate cancer with high metastatic risk, immediate androgen suppression with an LHRH agonist given during and for 3 years after external irradiation improves 10-year disease-free and overall survival without increasing late cardiovascular toxicity.